Extract

The purpose of this study is to enroll pre-liver transplant patients who will be vaccinated with either the novel adjuvanted HBV vaccine or double doses of Engerix™-B. The immunogenicity and safety of the novel adjuvanted vaccine will be compared to Engerix™-B as the control vaccine

Inclusion criteria

• Hepatitis B

Country

• Belgium
• France
• Germany
• Spain
• United Kingdom

Links

• gsk
• nct
• ictrp